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Background
Stevens-Johnson syndrome (SJS) and toxic epidermal
necrolysis (TEN), are severe adverse drug reactions
which are very rare, acute, serious, and potentially fatal.
They exhibit characteristic symptoms not only in the
skin, but also in the mucosal tissues such as ocular sur-
face, oral cavity, and genitals. Although antipyretic
analgesics (AAs) are some of the most frequent causative
drugs of SJS/TEN, there has been no HLA association
studies on these drugs-induced SJS/TEN. The scope of
this study is to investigate HLA-type association with
AA-related SJS/TEN with severe ocular surface complica-
tions (SOCs).
Method
Japanese SJS/TEN patients were recruited to this study
through the Japan Severe Adverse Reactions (JSAR)
research group. The SJS/TEN patients can be divided into
three groups: (i) patients with SOCs who received AA for
relieving a common cold before the onset of SJS/TEN (20
cases); (ii) patients without SOCs who received AA for
relieving a common cold before the onset of SJS/TEN (16
cases); (iii) patients with SOCs who received causative drug
(s) for relieving other than a common cold (38 cases). HLA
class I loci (HLA-A, C, and B) were genotyped for these
patients and for healthy Japanese volunteers (n = 220). For
these HLA genotypes, frequencies in the case groups were
compared with those in the healthy controls.
Results
Significant association of SJS/TEN with HLA-A*02:06 was
found in the group (i), as previously reported (Ueta et al,
Mol Vision 14:550 2008). In addition, we found significant
association with HLA-A*33:03-C*14:03-B*44:03 haplotype
in this group, which is the second most frequent haplotype
in Japanese population (5.605%). Fourteen patients of the
group (i) had been administered acetaminophen, and
these two HLA-type/haplotype associations were still sig-
nificant in the acetaminophen-administered subgroup of
the group (i). On the other hand, these two associations
were not significant either in the groups (ii) or (iii),
although there was a small difference in the frequency
of HLA-C*14:03-B*44:03 haplotype between groups
(i) and (ii).
Conclusion
In the Japanese population, we found that HLA-A*02:06
genotype and HLA-A*33:03-C*14:03-B*44:03 haplotype
are independently associated with AA-induced SJS/TEN
with SOCs. These biomarkers would be useful to discover
mechanisms of and to develop a new therapeutic method
for SOCs caused by AA-induced SJS/TEN.
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